1 |
What type of learning is discussed in relation to newborn infants in the context of sound sequences?
|
Statistical learning |
|
It is to test that newborn’s brains respond to rhythm, or perceiving an innate beat
|
It is also said in the article that they used statistical learning. The results also show that statistical learning doesn’t fully explain the beat process in infants.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
2 |
What experimental method was used to study the infants?
|
EEG experiments |
|
EEG experiments are studies that uses special sensors placed on the head to record the brain’s activity
|
EEG experiments are mainly used to study the brains activity when listening to beats.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
3 |
What was used to induce a beat in sound sequences during the study?
|
Isochronous timing |
|
They used Isochronous timing to induce a beat.
|
In the article, isochronous timing means that sounds were played at an equal, time intervals, like metronomes.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
4 |
What is a key outcome of beat perception studies in newborns?
|
Presence of beat processing |
|
Because in studies, its shown that even without learning, infants can detect regular rhythm patterns.
|
The article also mentions this.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
5 |
What does the mismatch response (MMR) indicate in newborn infants?
|
Regularity violation detection |
|
In newborns, MMR indicates that they notice when sounds doesn’t match the rhythm pattern.
|
The studies in the article shows that the MMR results shows clear difference between the sequences.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
6 |
What aspect of the sound was manipulated to test beat perception separately from statistical learning?
|
Timing (isochronous vs jittered) |
|
To test beat perception separately from statistical learning
|
Most of the other answers aren’t about timing or rhythm, and the article said they manipulated the timing.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
7 |
According to the study, why is the detection of a beat significant in newborns?
|
It predicts future language skills |
|
It can show that infants have an early developing to rhythm and timing.
|
Many studies shows that early rhythm may help infants develop language skills.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
8 |
How does the article describe the relationship between statistical learning and beat processing in newborns?
|
Completely independent |
|
The study shows that beat processing in infants cannot be shown or explained correctly by statistical learning.
|
The title itself already shows why. The other answers are either proven to be wrong or the study never shows.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
9 |
Which physiological measure was primarily used to assess responses to sound sequences in the study?
|
Electroencephalography (EEG) |
|
The study used EEG to measure newborns responded to sound sequences.
|
EEG is ideal for newborns since it is silent and records the brain activity in real time.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
10 |
What does the presence of a clear Mismatch Response (MMR) to beat and offbeat positions in an isochronous condition suggest about newborns' auditory capabilities?
|
Advanced capabilities in detecting rhythm |
|
The presence of a clear mismatch response, in isochronous conditions.
|
The study shows that the EEG recorded strong MMRs when a tone occurred off the beat the infants expected.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
11 |
What is the main focus of the cell and gene therapies article?
|
Evidence-based cell and gene therapies |
|
The question refers to the article
|
The title itself has already revealed its focus
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
12 |
What does CGT stand for in the context of the article?
|
Cell and Gene Therapies |
|
From the topic, the abbreviation CGT clearly stands for Cell and Gene therapies.
|
The entire article say about CGTs and the full name of it.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
13 |
What does the article caution against?
|
Direct-to-consumer marketing of unproven CGTs |
|
The article specifically warns about the direct to consumer marketing
|
The author in the article says that CGT’s should be offered after testing.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
14 |
According to the article, what is a risk associated with unproven CGTs?
|
All of the above |
|
The article clearly lists multiple risks associated with CGT .
|
All the sentences are mention in the article on how its a risk.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
15 |
Which platform is mentioned for registering research that might not be credible?
|
ClinicalTrials.gov |
|
The article warns the misuse of platforms, by promoting unproven research
|
The website is about allowing the public to see ongoing studies, but the article warns that it lacks proper information.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
16 |
What term is used to describe items that make unproven CGTs appear valid?
|
Tokens of Legitimacy |
|
The article refers to elements that give false information to unproven therapies, which are tokens of legitimacy
|
Tokens of legitimacy are signs or symbols that makes something appear real and believable, even if its not proven.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
17 |
What does the ISCT oppose according to the article?
|
Premature commercialization of unproven CGTs |
|
the ISCT states in the article that it opposes the early marketing and use of CGT, that lacks evidence.
|
There are direct quotes from the article itself, that warns that it put patients at risk.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
18 |
Which regulatory body is NOT mentioned in the article as a key player in CGT oversight?
|
CDC |
|
The article did not mention CDC
|
The article only mentioned the others, except for CDC, not on approving CGT.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
19 |
What specific role do 'tokens of legitimacy' play according to the article?
|
Persuade patients of the safety and efficacy of unproven CGTs |
|
The article uses tokens of legitimacy to describe elements that make unproven CGTs appear believable
|
Their purpose is to mislead patients that its safe.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
20 |
According to the article, what is a critical measure for distinguishing evidence-based CGTs?
|
Pre-marketing authorization by national regulatory bodies |
|
The article says that evidence CGTs must be formal approved by respected regulatory authorities.
|
Official approval is the key for evidence based therapies
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|